Steel Grove Capital Advisors’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.6M | Sell |
21,625
-301
| -1% | -$34.8K | 0.27% | 38 |
|
|
2025
Q4 | $2.31M | Sell |
21,926
-2,448
| -10% | -$230K | 0.24% | 41 |
|
|
2025
Q3 | $1.93M | Hold |
24,374
| – | – | 0.23% | 53 |
|
|
2025
Q2 | $1.93M | Buy |
24,374
+21,146
| +655% | +$1.68M | 0.23% | 53 |
|
|
2025
Q1 | $290K | Sell |
3,228
-120
| -4% | -$11.2K | 0.04% | 137 |
|
|
2024
Q4 | $333K | Sell |
3,348
-2,595
| -44% | -$268K | 0.05% | 141 |
|
|
2024
Q3 | $676K | Sell |
5,943
-205
| -3% | -$24.4K | 0.09% | 102 |
|
|
2024
Q2 | $761K | Sell |
6,148
-17,768
| -74% | -$2.29M | 0.11% | 93 |
|
|
2024
Q1 | $3.16M | Buy |
23,916
+790
| +3% | +$97.4K | 0.42% | 27 |
|
|
2023
Q4 | $2.52M | Sell |
23,126
-978
| -4% | -$102K | 0.34% | 34 |
|
|
2023
Q3 | $2.48M | Sell |
24,104
-548
| -2% | -$59.1K | 0.33% | 36 |
|
|
2023
Q2 | $2.84M | Buy |
24,652
+1,885
| +8% | +$214K | 0.36% | 36 |
|
|
2023
Q1 | $2.42M | Sell |
22,767
-2,798
| -11% | -$302K | 0.32% | 40 |
|
|
2022
Q4 | $2.84M | Buy |
25,565
+212
| +0.8% | +$21.7K | 0.4% | 32 |
|
|
2022
Q3 | $2.18M | Sell |
25,353
-589
| -2% | -$52.6K | 0.39% | 27 |
|
|
2022
Q2 | $2.37M | Buy |
25,942
+21,977
| +554% | +$1.95M | 0.43% | 24 |
|
|
2022
Q1 | $325K | Buy |
3,965
+56
| +1% | +$4.42K | 0.05% | 118 |
|
|
2021
Q4 | $300K | Sell |
3,909
-282
| -7% | -$22.5K | 0.06% | 116 |
|
|
2021
Q3 | $315K | Buy |
4,191
+1,088
| +35% | +$82.7K | 0.07% | 115 |
|
|
2021
Q2 | $241K | Buy |
3,103
+193
| +7% | +$14.4K | 0.07% | 119 |
|
|
2021
Q1 | $214K | Hold |
2,910
| – | – | 0.07% | 123 |
|
|
2020
Q4 | $227K | Hold |
2,910
| – | – | 0.07% | 118 |
|
|
2020
Q3 | $230K | Hold |
2,910
| – | – | 0.09% | 100 |
|
|
2020
Q2 | $215K | Buy |
+2,910
| New | +$219K | 0.1% | 103 |
|
|
2020
Q1 | – | Sell |
-22,760
| Closed | -$1.98M | – | 123 |
|
|
2019
Q4 | $1.98M | Buy |
22,760
+783
| +4% | +$64.3K | 1.1% | 20 |
|
|
2019
Q3 | $1.76M | Sell |
21,977
-65
| -0.3% | -$5.21K | 1.04% | 21 |
|
|
2019
Q2 | $1.76M | Sell |
22,042
-8,166
| -27% | -$625K | 1.1% | 21 |
|
|
2019
Q1 | $2.4M | Sell |
30,208
-98,763
| -77% | -$7.39M | 1.55% | 14 |
|
|
2018
Q4 | $9.47M | Sell |
128,971
-15,931
| -11% | -$1.12M | 1.34% | 13 |
|
|
2018
Q3 | $9.88M | Buy |
144,902
+9,904
| +7% | +$631K | 1.38% | 9 |
|
|
2018
Q2 | $7.88M | Sell |
134,998
-15,814
| -10% | -$892K | 1.26% | 12 |
|
|
2018
Q1 | $7.91M | Buy |
150,812
+16,610
| +12% | +$897K | 1.24% | 14 |
|
|
2017
Q4 | $7.27M | Buy |
134,202
+19,465
| +17% | +$1.08M | 1.09% | 35 |
|
|
2017
Q3 | $7.06M | Buy |
114,737
+7,731
| +7% | +$469K | 1.27% | 15 |
|
|
2017
Q2 | $6.57M | Sell |
107,006
-1,352
| -1% | -$82.3K | 1.17% | 31 |
|
|
2017
Q1 | $6.62M | Buy |
108,358
+17,169
| +19% | +$1.04M | 1.17% | 23 |
|
|
2016
Q4 | $5.16M | Buy |
91,189
+4,029
| +5% | +$236K | 1.03% | 30 |
|
|
2016
Q3 | $5.23M | Buy |
87,160
+6,074
| +7% | +$355K | 1.18% | 18 |
|
|
2016
Q2 | $4.49M | Buy |
81,086
+1,770
| +2% | +$94.2K | 1.11% | 22 |
|
|
2016
Q1 | $4.04M | Buy |
79,316
+40,356
| +104% | +$1.98M | 1.03% | 35 |
|
|
2015
Q4 | $1.98M | Sell |
38,960
-47,258
| -55% | -$2.38M | 0.49% | 67 |
|
|
2015
Q3 | $4.1M | Sell |
86,218
-16,464
| -16% | -$875K | 1.02% | 34 |
|
|
2015
Q2 | $5.62M | Buy |
102,682
+7,223
| +8% | +$405K | 1.25% | 22 |
|
|
2015
Q1 | $5.28M | Buy |
+95,459
| New | +$5.41M | 1.19% | 32 |
|
Other funds holding MRK
VCM
VPM
Steel Grove Capital Advisors's MRK Position: Q1 2026 in Review
Steel Grove Capital Advisors reduced its Merck (MRK) stake by 1.4% in Q1 2026, selling an estimated $34.8K and leaving 21,625 shares worth $2.6M. The position accounts for 0.27% of the portfolio, ranked #38.
Steel Grove Capital Advisors first reported a position in MRK in Q1 2015 and has held it in 44 quarters since. The position peaked at $9.88M in Q3 2018. 3,779 funds tracked by Wall St. Rank hold MRK as of Q1 2026.
- Steel Grove Capital Advisors held 21,625 shares of Merck worth $2.6M as of Q1 2026.
- Steel Grove Capital Advisors sold 301 Merck shares in Q1 2026, an estimated $34.8K.
- Merck made up 0.27% of Steel Grove Capital Advisors's portfolio in Q1 2026, its #38 holding.
- Steel Grove Capital Advisors first reported a position in Merck in Q1 2015 and has held it in 44 quarters since.
- Steel Grove Capital Advisors's Merck position peaked at $9.88M in Q3 2018.
- 3,779 funds tracked by Wall St. Rank held Merck as of Q1 2026.
Based on Steel Grove Capital Advisors's 13F filing for Q1 2026, filed 7 May 2026.